Therefore, in future scenarios, PKCε-specific miRs and inhibitory peptides could be enrolled for innovative and more effective combined therapies in which nanoparticles will be used to specifically reach tumor cells, penetrating through the characteristic desmoplastic stroma of PDAC. The gene discussed is PRKCE; the disease is neoplasm.